• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 102208-905
Device Problem Imprecision (1307)
Patient Problem Hypoglycemia (1912)
Event Date 07/09/2023
Event Type  Injury  
Manufacturer Narrative
The investigation was performed on the user synced glucose data on data management system (dms), which is an eversense cloud platform.Based on the review of the glucose data, the sensor glucose (sg) value was 329 mg/dl at 6:06 pm, but there was no blood glucose (bg) entry.Customer reported that the bg value was 35 mg/dl after injecting the insulin of 5.37 units based on the sg value of 329 mg/dl.A review of the sensor raw data did not reveal any performance malfunction or any abnormalities.Overall, the bg and sg values fit well with some occasional differences due to lag, which is inherent to any cgm system, and due to calibration during the periods of rapid glucose changes.Therefore, it can be concluded that the sensor was performing within expectations.The most probable root cause of the reported incident can be due to the insulin dosage which could have lowered the bg value.No further investigation was found necessary for this complaint.
 
Event Description
Senseonics was made aware of a customer experiencing a hypoglycemia event on (b)(6) 2023 at 06:10 pm.The customer reported that the measured blood glucose (bg) value was 35 mg/dl where as the sensor glucose (sg) reading was 329 mg/dl.The customer experienced this event while driving, after having spent a day at the pool.Prior to the incident at 05:37 pm, the customer had administered insulin based on the sg value shown by the eversense system.The insulin dosage lowered the bg resulting in a hypoglycemia event.The customer did not receive a low glucose alert at the time of incident, but instead received a high glucose alert because the sg value was above the high alert threshold.The customer self resolved the incident by drinking a cola.The customer did not require any medical attention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown 20876-7005
MDR Report Key18117235
MDR Text Key327866347
Report Number3009862700-2023-00280
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/26/2023
Device Model Number102208-905
Device Catalogue NumberFG-3500-05-001
Device Lot Number134547
Was Device Available for Evaluation? No
Date Manufacturer Received08/26/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/26/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-